These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24227634)

  • 21. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children.
    Mbawuike IN; Wells J; Byrd R; Cron SG; Glezen WP; Piedra PA
    J Infect Dis; 2001 Mar; 183(5):687-96. PubMed ID: 11181144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
    Sarkar I; Garg R; van Drunen Littel-van den Hurk S
    Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus.
    Levitz R; Gao Y; Dozmorov I; Song R; Wakeland EK; Kahn JS
    PLoS One; 2017; 12(9):e0184318. PubMed ID: 28877226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.
    Johnson TR
    Expert Rev Vaccines; 2006 Jun; 5(3):371-80. PubMed ID: 16827621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RSV, Antibodies and the Developing World.
    Murray A; Chu HY
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S24-S27. PubMed ID: 31205240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
    Harris J; Werling D
    Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.
    Sedeyn K; Schepens B; Saelens X
    PLoS Pathog; 2019 Oct; 15(10):e1007984. PubMed ID: 31622448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
    Piedra FA; Mei M; Avadhanula V; Mehta R; Aideyan L; Garofalo RP; Piedra PA
    PLoS One; 2017; 12(3):e0172953. PubMed ID: 28267794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate immune responses to respiratory syncytial virus infection.
    Mukherjee S; Lukacs NW
    Curr Top Microbiol Immunol; 2013; 372():139-54. PubMed ID: 24362688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs.
    Olivier A; Gallup J; de Macedo MM; Varga SM; Ackermann M
    Int J Exp Pathol; 2009 Aug; 90(4):431-8. PubMed ID: 19659901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of neonates and infants by maternal immunization.
    Gerdts V; van Drunen Littel-van den Hurk S; Potter A
    Expert Rev Vaccines; 2016 Nov; 15(11):1347-1349. PubMed ID: 27248694
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.
    Whelan JN; Tran KC; van Rossum DB; Teng MN
    J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immune responses in respiratory syncytial virus infections.
    Krishnan S; Halonen M; Welliver RC
    Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.
    Marr N; Turvey SE; Grandvaux N
    Trends Microbiol; 2013 Nov; 21(11):568-74. PubMed ID: 24119913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in and the potential of vaccines for respiratory syncytial virus.
    Jorquera PA; Oakley KE; Tripp RA
    Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus disease: prevention and treatment.
    Chu HY; Englund JA
    Curr Top Microbiol Immunol; 2013; 372():235-58. PubMed ID: 24362693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.